Search research articles
Contact Us
Filters
Showing results (101-110 of 207) with videos related to
Page
of 21
Sort By:
Current Treatment Options in Oncology
|
January 25, 2024
Impact of PSMA PET on Prostate Cancer Management
Adam B Weiner, Raag Agrawal, Luca F Valle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 2024
Prostate-Specific Membrane Antigen PET/CT-Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
John Nikitas, Angela Castellanos Rieger, Andrea Farolfi, et al.
BMC Cancer
|
May 8, 2021
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
Jeremie Calais, Shaojun Zhu, Nader Hirmas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study
Rong Rong Huang, Chunlai Zuo, Christine E Mona, et al.
Clinical Genitourinary Cancer
|
October 9, 2018
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by <sup>68</sup>Ga-PSMA-11 PET/CT
Giulia Polverari, Francesco Ceci, Martin Allen-Auerbach, et al.
EJNMMI Research
|
October 16, 2020
[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
Giulia Polverari, Francesco Ceci, Roberto Passera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
Ida Sonni, Matthias Eiber, Wolfgang P Fendler, et al.
European Urology Oncology
|
September 22, 2020
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study
Andrew T Lenis, Aydin Pooli, Patrick M Lec, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
Andrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 21, 2019
Can the Injected Dose Be Reduced in <sup>68</sup>Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?
Isabel Rauscher, Wolfgang P Fendler, Thomas A Hope, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 207) with videos related to
Sort By:
Page
of 21
Current Treatment Options in Oncology
|
January 25, 2024
Impact of PSMA PET on Prostate Cancer Management
Adam B Weiner, Raag Agrawal, Luca F Valle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 2024
Prostate-Specific Membrane Antigen PET/CT-Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
John Nikitas, Angela Castellanos Rieger, Andrea Farolfi, et al.
BMC Cancer
|
May 8, 2021
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
Jeremie Calais, Shaojun Zhu, Nader Hirmas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study
Rong Rong Huang, Chunlai Zuo, Christine E Mona, et al.
Clinical Genitourinary Cancer
|
October 9, 2018
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by <sup>68</sup>Ga-PSMA-11 PET/CT
Giulia Polverari, Francesco Ceci, Martin Allen-Auerbach, et al.
EJNMMI Research
|
October 16, 2020
[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
Giulia Polverari, Francesco Ceci, Roberto Passera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
Ida Sonni, Matthias Eiber, Wolfgang P Fendler, et al.
European Urology Oncology
|
September 22, 2020
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study
Andrew T Lenis, Aydin Pooli, Patrick M Lec, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
Andrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 21, 2019
Can the Injected Dose Be Reduced in <sup>68</sup>Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?
Isabel Rauscher, Wolfgang P Fendler, Thomas A Hope, et al.
Page
of 21